Prasad Adusumilli, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1689877037
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,936 of the $46,318 with a category attached, or 71.1%. 7 manufacturers reported payments, led by Orion Corporation at 44.3% of the total. Reporting peaked in 2021 at $15,759 and has fallen 55.6% since, to $7,000 in 2025.
Across 20 payments — averaging $2315.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orion Corporation$21K
- Novocure GmbH$9K
- Bayer$7K
- Intuitive Surgical$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- AstraZeneca$2K
- plus $1K from 1 others
Across 13 payments — averaging $147,198 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure Inc.$1.9M
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Consulting fees$32,93671%
- Speaking & faculty fees$9,45220%
- Travel & lodging$6491%
- Food & beverage$2811%
- Education$3,0006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orion Corporation | 4 | $20,500 |
| Novocure GmbH | 2 | $9,452 |
| Bayer | 2 | $7,300 |
| Intuitive Surgical | 8 | $3,834 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,600 |
| AstraZeneca | 1 | $1,611 |
| Novocure Inc. | 2 | $1,021 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered$6,500
- Da Vinci Surgical System$3,786
- TAGRISSO$1,611
- NovoTTF-100L$925
How this compares
$46,318 in reported general payments places this provider in the 85th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.
See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in New York
- Aubrey GallowayNew York$5.7M
- Gilbert TangNew York$842K
- Michael ZervosNew York$811K
- Elias ZiasNew York$465K
- Isaac GeorgeNew York$395K
- Eugene GrossiNew York$350K
- Costas BizekisNew York$321K
- Brendon StilesNew York$314K
- Daniela MolenaNew York$221K
- Arnar GeirssonNew York$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.